HHS offers limited supply of COVID-19 treatment for uninsured

The Health and Human Services Department is purchasing 60,000 COVID-19 monoclonal antibody treatment doses as federal funding runs dry, the department announced Friday.

The initiative will give uninsured and underinsured Americans no-cost access to bebtelovimab, a monoclonal antibody treatment that reached the commercial market last month. HHS will resupply the drug at no cost to providers that use it to treat patients who lack adequate…